Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C496751 |
4-(1H-imidazol-1-yl)retinoic acid |
4-(1H-imidazol-1-yl)retinoic acid results in decreased expression of NCOA3 protein | decreases expression | 17145897
|
C496751 |
4-(1H-imidazol-1-yl)retinoic acid |
4-(1H-imidazol-1-yl)retinoic acid results in decreased expression of NCOA3 protein | decreases expression | 17145897
|
D013196 |
Dihydrotestosterone |
NCOA3 protein promotes the reaction [Dihydrotestosterone results in increased expression of AR mRNA] | increases expression|increases reaction | 16877366
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NCOA3 mRNA | affects expression | 16483693
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of NCOA3 mRNA | affects expression | 17331233
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of NCOA3 mRNA | decreases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of NCOA3 mRNA | decreases expression | 19150397 17944540
|
C072553 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tretinoin results in increased degradation of NCOA3 protein] | decreases reaction|increases degradation | 16456540
|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of NCOA3 mRNA | decreases expression | 16474171
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of NCOA3 mRNA | decreases expression | 20106945
|
C107676 |
deguelin |
deguelin results in decreased expression of NCOA3 mRNA | decreases expression | 19365708
|
C107676 |
deguelin |
deguelin results in decreased expression of NCOA3 protein | decreases expression | 19365708
|
D002945 |
Cisplatin |
Cisplatin promotes the reaction [NR1I2 protein binds to NCOA3 protein] | affects binding|increases reaction | 15650019
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [[VDR protein binds to NCOA3 protein] which binds to CYP24A1 promoter] | affects binding|increases reaction | 15919092
|
D002117 |
Calcitriol |
Calcitriol affects the localization of NCOA3 protein | affects localization | 15647825
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [NCOA3 protein binds to CYP24A1 promoter] | affects binding|increases reaction | 15647825
|
D002117 |
Calcitriol |
Calcitriol promotes the reaction [NCOA3 protein binds to SPP1 promoter] | affects binding|increases reaction | 15647825
|
D004958 |
Estradiol |
BRCA1 protein affects the reaction [Estradiol promotes the reaction [ESR1 protein binds to NCOA3 protein]] | affects binding|affects reaction|increases reaction | 18997820
|
D004958 |
Estradiol |
ESR1 protein affects the reaction [Estradiol promotes the reaction [NCOA3 protein binds to CECR6 gene]] | affects binding|affects reaction|increases reaction | 17962382
|
D004958 |
Estradiol |
ESR1 protein affects the reaction [Estradiol promotes the reaction [NCOA3 protein binds to H19 gene]] | affects binding|affects reaction|increases reaction | 17962382
|
D004958 |
Estradiol |
ESR1 protein affects the reaction [Estradiol promotes the reaction [NCOA3 protein binds to KLRC1 gene]] | affects binding|affects reaction|increases reaction | 17962382
|
D004958 |
Estradiol |
ESR1 protein affects the reaction [Estradiol promotes the reaction [NCOA3 protein binds to NKD1 gene]] | affects binding|affects reaction|increases reaction | 17962382
|
D004958 |
Estradiol |
ESR1 protein affects the reaction [Estradiol promotes the reaction [NCOA3 protein binds to SPATA13 gene]] | affects binding|affects reaction|increases reaction | 17962382
|
D004958 |
Estradiol |
Estradiol promotes the reaction [ESR1 protein binds to NCOA3 protein] | affects binding|increases reaction | 18997820
|
D004958 |
Estradiol |
Estradiol promotes the reaction [NCOA3 protein binds to ESR1 promoter] | affects binding|increases reaction | 19620290
|
D004958 |
Estradiol |
Estradiol promotes the reaction [NCOA3 protein binds to IGF1 promoter] | affects binding|increases reaction | 17872375
|
D004958 |
Estradiol |
Estradiol promotes the reaction [NCOA3 protein binds to KLRC3 gene] | affects binding|increases reaction | 17395694
|
D004958 |
Estradiol |
Estradiol promotes the reaction [NCOA3 protein binds to PTGS2 promoter] | affects binding|increases reaction | 17872375
|
D004958 |
Estradiol |
Estradiol results in decreased expression of NCOA3 mRNA | decreases expression | 16474171
|
D004958 |
Estradiol |
Estradiol results in decreased expression of NCOA3 protein | decreases expression | 16739346
|
D004958 |
Estradiol |
Estradiol results in increased expression of NCOA3 mRNA | increases expression | 20068009
|
D019833 |
Genistein |
Genistein results in decreased expression of NCOA3 mRNA | decreases expression | 16474171
|
C423914 |
LG 268 |
LG 268 promotes the reaction [NCOA3 protein binds to [RXRA protein binds to RXRA protein]] | affects binding|increases reaction | 15310754
|
D008043 |
Linseed Oil |
Linseed Oil results in decreased expression of NCOA3 protein | decreases expression | 21138602
|
D008628 |
Mercury |
Mercury results in increased expression of NCOA3 mRNA | increases expression | 16823088
|
D015741 |
Metribolone |
Metribolone inhibits the reaction [NCOA3 protein results in increased activity of AR protein] | decreases reaction|increases activity | 11981028
|
D017239 |
Paclitaxel |
Paclitaxel promotes the reaction [NR1I2 protein binds to NCOA3 protein] | affects binding|increases reaction | 15650019
|
D011078 |
Polychlorinated Biphenyls |
Polychlorinated Biphenyls analog results in decreased expression of NCOA3 mRNA | decreases expression | 16474171
|
D020849 |
Raloxifene |
Raloxifene promotes the reaction [NCOA3 protein binds to IGF1 promoter] | affects binding|increases reaction | 17872375
|
D020849 |
Raloxifene |
Raloxifene promotes the reaction [NCOA3 protein binds to KLRC3 gene] | affects binding|increases reaction | 17395694
|
D020849 |
Raloxifene |
Raloxifene promotes the reaction [NCOA3 protein binds to PTGS2 promoter] | affects binding|increases reaction | 17872375
|
D012402 |
Rotenone |
Rotenone results in increased expression of NCOA3 mRNA | increases expression | 19013527
|
D013629 |
Tamoxifen |
BRCA1 protein affects the reaction [Tamoxifen promotes the reaction [ESR1 protein binds to NCOA3 protein]] | affects binding|affects reaction|increases reaction | 18997820
|
D013629 |
Tamoxifen |
NCOA3 results in decreased susceptibility to Tamoxifen | decreases response to substance | 21059860
|
D013629 |
Tamoxifen |
Tamoxifen promotes the reaction [NCOA3 protein binds to KLRC3 gene] | affects binding|increases reaction | 17395694
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of NCOA3 mRNA | increases expression | 20332317 20215421
|
D013629 |
Tamoxifen |
Tamoxifen results in increased expression of NCOA3 protein | increases expression | 20215421
|
C004648 |
testosterone enanthate |
testosterone enanthate results in increased expression of NCOA3 mRNA | increases expression | 17440010
|
D013749 |
Tetrachlorodibenzodioxin |
NCOA3 protein promotes the reaction [Tetrachlorodibenzodioxin results in increased activity of [AHR protein binds to ARNT protein]] | affects binding|increases activity|increases reaction | 12024042
|
D013749 |
Tetrachlorodibenzodioxin |
NCOA3 protein promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] | increases expression|increases reaction | 12024042
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin promotes the reaction [NCOA3 protein binds to CYP1A1 enhancer] | affects binding|increases reaction | 12024042
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of NCOA3 mRNA | decreases expression | 20106945
|
D014212 |
Tretinoin |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Tretinoin results in increased degradation of NCOA3 protein] | decreases reaction|increases degradation | 16456540
|
D014212 |
Tretinoin |
[RARA protein binds to RXRA protein] promotes the reaction [Tretinoin results in increased degradation of NCOA3 protein] | affects binding|increases degradation|increases reaction | 16456540
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [NCOA3 protein binds to HAS2 promoter] | affects binding|increases reaction | 17307735
|
D014212 |
Tretinoin |
Tretinoin promotes the reaction [NCOA3 protein binds to RARA protein] | affects binding|increases reaction | 16456540
|
D014212 |
Tretinoin |
[Tretinoin results in increased activity of MAPK14 protein] which results in increased phosphorylation of and results in increased degradation of NCOA3 protein | increases activity|increases degradation|increases phosphorylation | 16456540
|
D014212 |
Tretinoin |
Tretinoin results in increased degradation of NCOA3 protein | increases degradation | 16456540
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of NCOA3 mRNA | increases expression | 17218384
|
D014212 |
Tretinoin |
Tretinoin results in increased phosphorylation of NCOA3 protein | increases phosphorylation | 16456540
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of NCOA3 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.32 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.55 | 15322242 14514962 11752688 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.55 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.72 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.33 | 18287403 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
3.75 | 12690470 15814532 17670903 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
9.71 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
9.71 | 17638652 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
9.71 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
9.71 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.52 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.15 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.38 | 17451421 17308373 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.44 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.49 | 15800139 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.00 | 17688650 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.75 | 11748828 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.39 | 17497229 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.85 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
2.94 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.21 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.28 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.35 | 17497416 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.35 | 16609825 19460635 18177632 17507914 18558336 17157402 20603192 18940202 18316065 17688650 18985861 18396377 18775368 19232924 15238991 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
4.65 | 16634805 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.18 | 16935849 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
2.96 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.26 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
8.26 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.56 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.54 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.54 | 8888407 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
4.65 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.36 | 15867366 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.66 | 11985600 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.25 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 20332317 |
MESH:D001943 |
Breast Neoplasms |
|
4-(1H-imidazol-1-yl)retinoic acid |
12.40 | 17387344 17145897 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
12.40 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
12.40 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
12.40 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
12.40 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
deguelin |
12.40 | 17035597 18593368 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
12.40 | 19861407 12948864 18497071 16675129 17289903 17261762 17018787 14630087 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
12.40 | 16873071 16541309 17200150 |
MESH:D001943 |
Breast Neoplasms |
|
Linseed Oil |
12.40 | 21138602 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
12.40 | 15136595 11325840 18323546 16115903 16244791 18223236 16273361 18234424 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
12.40 | 15758505 15572757 16837676 17952589 17595753 15775269 17893378 17261762 16912660 17049068 17242785 17440819 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
12.40 | 16273361 19189212 17049068 17261762 19289846 19189210 20065188 18351453 17242785 20135344 16873071 19155303 19487384 19115204 20005174 17893378 17440819 20390343 20859285 19011961 19066611 19221464 19142967 21152245 19059307 15668708 18997820 15565566 16818667 19084267 18855134 18815881 19244106 11161223 18629630 19200415 19410462 20544844 19288272 21138602 19103187 16202921 18821012 18984771 18425577 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
12.40 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
12.40 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.36 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.23 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.62 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.28 | 19066611 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
4.93 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
13.50 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
deguelin |
13.50 | 18575727 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
13.50 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
13.50 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
13.50 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
13.50 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
13.50 | 1917145 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.76 | 17123778 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
2.96 | 12023789 16685392 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
10.25 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
10.25 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
10.25 | 17066447 6189445 18337622 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
10.25 | 16096774 16051514 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
8.84 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
8.84 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.24 | 16120746 18670907 18850075 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
3.37 | 10334427 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
6.98 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
6.98 | 15775269 |
MESH:D002386 |
Cataract |
|
Tretinoin |
2.96 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.24 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
10.24 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
10.24 | 18566989 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.36 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.63 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.97 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
2.75 | 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
4.93 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.45 | 16354765 8697196 15340226 12621046 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.45 | 9407595 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.39 | 15800139 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.48 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.25 | 17182828 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
3.56 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
3.56 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Polychlorinated Biphenyls |
3.56 | 15531428 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.87 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.61 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.61 | 14991402 9224671 8800419 9211117 10589399 16925845 17551590 9142499 9125849 9664655 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.61 | 17688650 8888407 16575769 |
MESH:D003704 |
Dementia |
|
Polychlorinated Biphenyls |
4.50 | 16140633 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.14 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
3.97 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
3.58 | 16823706 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
4.13 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.13 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
13.91 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
13.91 | 17308373 17451421 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
13.91 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.55 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
3.55 | 1733752 19641884 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
7.62 | 12649298 19839026 12231392 15033597 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.62 | 11462148 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.84 | 1851702 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.18 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.18 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.17 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.17 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
14.19 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
14.19 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
14.19 | 19031437 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
4.36 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
16.57 | 18566989 11473722 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
16.57 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
16.57 | 19155303 20544844 16202921 17893378 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
16.57 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.82 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
3.93 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.69 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.82 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.40 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.07 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.84 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
9.93 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
9.93 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
9.93 | 16481741 15173087 16785472 15464296 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
9.93 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.28 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.28 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
17.11 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
17.11 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
17.11 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
17.11 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.10 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.23 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.66 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
3.91 | 8888407 18558336 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.30 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
3.95 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
13.42 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.42 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
13.42 | 17994277 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.99 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
6.72 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
6.72 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.36 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
7.41 | 15102660 15464296 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.41 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
4.10 | 19898482 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
4.93 | 16084493 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
4.23 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
10.40 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
10.40 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
10.40 | 14991402 9664655 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.38 | 11110106 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.19 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.13 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.67 | 15340226 16120746 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.80 | 15709030 |
MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
5.52 | 17440010 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
3.41 | 16200630 16170182 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.52 | 17088409 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.64 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.81 | 8697196 16959395 18606429 16354765 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.04 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.34 | 16778211 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
8.07 | 10903974 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
8.07 | 17577099 15787275 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
8.07 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.50 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.50 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
6.95 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.95 | 16393666 16627594 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.54 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.25 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.25 | 17551590 15992940 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.21 | 15604871 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.91 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
13.43 | 15190930 12649298 19839026 12231392 18289764 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
13.43 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
13.43 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
13.43 | 17934191 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
11.31 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.31 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
11.31 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.56 | 11231351 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.28 | 16973256 |
MESH:D007938 |
Leukemia |
marker/mechanism |
|
| 19365708 |
MESH:D007938 |
Leukemia |
|
Genistein |
6.03 | 17468513 18980019 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
6.03 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.49 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.74 | 19850784 16294345 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.74 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.01 | 12679006 16823087 17217047 17294898 17107899 16788101 19642359 17649720 16935935 19075265 17301526 9834237 16331271 16891316 15748426 17712046 19225113 17361223 17368321 19035177 16766008 16140955 17506722 19029980 17339181 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.15 | 9224671 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.99 | 17567588 15342952 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.61 | 17353645 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.41 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
6.41 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
6.41 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.41 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.41 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
6.85 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
6.85 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
6.85 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Polychlorinated Biphenyls |
5.66 | 1423854 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.66 | 12151625 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.03 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
3.80 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
6.30 | 18816296 6695378 18569708 20135361 20464547 20064080 17053015 20869020 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
6.30 | 17225452 11798837 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
deguelin |
6.30 | 19336726 16288123 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
6.30 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.30 | 11884234 19555203 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
3.91 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.53 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.14 | 17203775 11807958 11408345 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
9.14 | 12929590 14578162 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.14 | 11731420 16827153 14580682 19196722 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
11.87 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
11.87 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.70 | 17453147 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
6.99 | 12883367 17761969 11135225 15577323 12393984 16248763 18332650 16432458 17023156 18505091 12374674 16809738 18176117 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
6.99 | 12040289 16342250 12025231 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
6.99 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
6.99 | 16752155 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
10.74 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
10.74 | 15990972 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.20 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
6.20 | 16166281 16966607 18303189 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
6.20 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.56 | 16801185 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.03 | 18803445 18765137 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.32 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.02 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
7.09 | 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
7.09 | 16497877 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.82 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
6.97 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
6.97 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
2.77 | 17141266 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.84 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
7.94 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
7.94 | 17141266 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.32 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
5.68 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
5.68 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.44 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
11.03 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
11.03 | 16773208 |
MESH:D009369 |
Neoplasms |
|
deguelin |
11.03 | 17764071 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
11.03 | 16946489 16594593 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.77 | 19196722 19189210 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.50 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
4.26 | 15464296 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.21 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.09 | 18481113 19348381 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.71 | 17356569 15790535 18619942 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
28.40 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
28.40 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
28.40 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
28.40 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
28.40 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
6.82 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
6.82 | 16359493 8888407 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
3.33 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.47 | 8761367 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.75 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
6.87 | 19401787 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
6.87 | 17882678 19059307 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
9.44 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
9.44 | 15758505 17823083 15579764 17893378 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.76 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
14.21 | 6897625 19769630 15464296 17225452 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
14.21 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
14.21 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
14.21 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
14.21 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.72 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
5.19 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.19 | 15976015 |
MESH:D010300 |
Parkinson Disease |
|
Polychlorinated Biphenyls |
5.51 | 16702228 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
5.51 | 19114014 15451049 11535288 16412576 18619942 18191903 19232380 16140633 11445065 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.88 | 15927086 15795934 15574749 18197244 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.02 | 12520081 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
4.09 | 15464296 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.67 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
5.11 | 17638057 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.34 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.03 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
14.91 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
14.91 | 11118676 11896295 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
14.91 | 20603192 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.55 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.87 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.87 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 11927493 12237244 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.88 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.88 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.88 | 16289102 12479363 15754350 18247401 16644109 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.88 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
2.88 | 15378649 16925846 15256057 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.88 | 17172428 17136230 16729912 16356831 |
MESH:D011471 |
Prostatic Neoplasms |
|
Polychlorinated Biphenyls |
2.88 | 15721890 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.88 | 16220300 16536755 15731164 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.88 | 15067354 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.39 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.31 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.15 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.56 | 16723453 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.56 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
2.94 | 17975199 17365031 17322281 15814490 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.32 | 15770314 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
4.18 | 15464296 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.16 | 16116481 16283617 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.16 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
4.21 | 14601052 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.04 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.59 | 1511512 16876388 14763951 17978042 3137016 11738929 15475178 11044598 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
12.74 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
deguelin |
12.74 | 16041863 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
12.74 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
12.74 | 16467112 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
5.11 | 15464296 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.06 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.81 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.61 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.31 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
4.57 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
4.57 | 18396642 15958060 17522103 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
4.57 | 18506536 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
4.57 | 17261132 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.64 | 16837676 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.76 | 16684133 16045194 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.58 | 16930453 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.42 | 15464296 17225452 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.67 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
2.86 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
12.94 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
12.94 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.59 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.00 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.09 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.29 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
11.22 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
11.22 | 17225452 12973940 15464296 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
11.22 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
11.22 | 16712894 8653321 17572228 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.42 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
8.91 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
8.91 | 16129372 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.78 | 14652134 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.38 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.75 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
4.39 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.36 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
4.98 | 16837676 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.84 | 16761959 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.49 | 11897121 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.32 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.02 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.78 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.21 | 17120751 |